BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31710779)

  • 41. Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group.
    Hettmer S; Dachy G; Seitz G; Agaimy A; Duncan C; Jongmans M; Hirsch S; Kventsel I; Kordes U; de Krijger RR; Metzler M; Michaeli O; Nemes K; Poluha A; Ripperger T; Russo A; Smetsers S; Sparber-Sauer M; Stutz E; Bourdeaut F; Kratz CP; Demoulin JB
    Fam Cancer; 2021 Oct; 20(4):327-336. PubMed ID: 32888134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PDGRFB mutation-associated myofibromatosis: Response to targeted therapy with imatinib.
    Weller JM; Keil VC; Gielen GH; Herrlinger U; Schäfer N
    Am J Med Genet A; 2019 Sep; 179(9):1895-1897. PubMed ID: 31291054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel
    Hassan M; Butler E; Wilson R; Roy A; Zheng Y; Liem P; Rakheja D; Pavlick D; Young LL; Rosenzweig M; Erlich R; Ali SM; Leavey PJ; Parsons DW; Skapek SX; Laetsch TW
    Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31645346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PDGFRB and NOTCH3 Mutations are Detectable in a Wider Range of Pericytic Tumors, Including Myopericytomas, Angioleiomyomas, Glomus Tumors, and Their Combined Tumors.
    Iwamura R; Komatsu K; Kusano M; Kubo C; Inaba Y; Shiba E; Nawata A; Tajiri R; Matsuyama A; Matoba H; Koga K; Takeda M; Itami H; Hisaoka M
    Mod Pathol; 2023 Mar; 36(3):100070. PubMed ID: 36788105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary familial brain calcification: update on molecular genetics.
    Taglia I; Bonifati V; Mignarri A; Dotti MT; Federico A
    Neurol Sci; 2015 May; 36(5):787-94. PubMed ID: 25686613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification.
    Nicolas G; Pottier C; Maltête D; Coutant S; Rovelet-Lecrux A; Legallic S; Rousseau S; Vaschalde Y; Guyant-Maréchal L; Augustin J; Martinaud O; Defebvre L; Krystkowiak P; Pariente J; Clanet M; Labauge P; Ayrignac X; Lefaucheur R; Le Ber I; Frébourg T; Hannequin D; Campion D
    Neurology; 2013 Jan; 80(2):181-7. PubMed ID: 23255827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.
    Bielorai B; Leitner M; Goldstein G; Mehrian-Shai R; Trakhtenbrot L; Fisher T; Marcu V; Yalon M; Schiby G; Barel O; Cal N; Golan H; Toren A
    Acta Haematol; 2019; 141(2):119-127. PubMed ID: 30726835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.
    Baxter EJ; Kulkarni S; Vizmanos JL; Jaju R; Martinelli G; Testoni N; Hughes G; Salamanchuk Z; Calasanz MJ; Lahortiga I; Pocock CF; Dang R; Fidler C; Wainscoat JS; Boultwood J; Cross NC
    Br J Haematol; 2003 Jan; 120(2):251-6. PubMed ID: 12542482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders.
    Gallagher G; Horsman DE; Tsang P; Forrest DL
    Cancer Genet Cytogenet; 2008 Feb; 181(1):46-51. PubMed ID: 18262053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carpal tunnel syndrome in paediatric patients: A novel association with Kosaki overgrowth syndrome.
    Walker H; Foster A; Cole T; Jester A
    JPRAS Open; 2020 Sep; 25():83-87. PubMed ID: 32904243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Marked response to imatinib mesylate in a patient with platelet-derived growth factor receptor beta-associated acute myeloid leukemia.
    Shimomura Y; Maruoka H; Ishikawa T
    Int J Hematol; 2017 May; 105(5):697-701. PubMed ID: 28000100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of PDGFRB Mutations With Pediatric Myofibroma and Myofibromatosis.
    Dachy G; de Krijger RR; Fraitag S; Théate I; Brichard B; Hoffman SB; Libbrecht L; Arts FA; Brouillard P; Vikkula M; Limaye N; Demoulin JB
    JAMA Dermatol; 2019 Aug; 155(8):946-950. PubMed ID: 31017643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate.
    Zou YS; Hoppman NL; Singh ZN; Sawhney S; Kotiah SD; Baer MR
    Cancer Genet; 2017 Apr; 212-213():38-44. PubMed ID: 28449810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Heterogenous abnormality polymorphism of gene PDGFRB in myeloid neoplasms and its clinical characteristics].
    Wang QS; Gao L; Jing Y; Zhu HY; Yang H; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):291-5. PubMed ID: 22541084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Premature Aging Syndrome, Penttinen Type: Report of a Chinese Case with a PDGFRB Mutation.
    Zhang Z; Zheng S; Zheng S; Wang Y; Xu XG; Gao XH; Chen HD
    Acta Derm Venereol; 2018 Oct; 98(9):912-913. PubMed ID: 29944170
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).
    Heinrich MC; McArthur GA; Demetri GD; Joensuu H; Bono P; Herrmann R; Hirte H; Cresta S; Koslin DB; Corless CL; Dirnhofer S; van Oosterom AT; Nikolova Z; Dimitrijevic S; Fletcher JA
    J Clin Oncol; 2006 Mar; 24(7):1195-203. PubMed ID: 16505440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of expressivity in PDGFRB-related infantile myofibromatosis: a role for PTPRG?
    Linhares ND; Freire MC; Cardenas RG; Bahia M; Puzenat E; Aubin F; Pena SD
    Genet Mol Res; 2014 Aug; 13(3):6287-92. PubMed ID: 25158255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet-derived growth factor receptor-beta constitutive activity promotes angiogenesis in vivo and in vitro.
    Magnusson PU; Looman C; Ahgren A; Wu Y; Claesson-Welsh L; Heuchel RL
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2142-9. PubMed ID: 17656670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene.
    Walz C; Metzgeroth G; Haferlach C; Schmitt-Graeff A; Fabarius A; Hagen V; Prümmer O; Rauh S; Hehlmann R; Hochhaus A; Cross NC; Reiter A
    Haematologica; 2007 Feb; 92(2):163-9. PubMed ID: 17296564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
    Savage N; George TI; Gotlib J
    Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.